121 – 130 of 1293
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(26). p.15172-15181(
- Contribution to journal › Article
-
Mark
Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB
(
- Contribution to journal › Article
-
Mark
Reduced Apolipoprotein M and Adverse Outcomes across the Spectrum of Human Heart Failure
(
- Contribution to journal › Article
-
Mark
Proteomic analysis enables distinction of early- versus advanced-stage lung adenocarcinomas
(
- Contribution to journal › Article
-
Mark
Advances in understanding mechanisms of thrombophilic disorders
(
- Contribution to journal › Scientific review
-
Mark
Kardiellt troponin – en biomarkör för hjärt–kärlsjukdom vid KOL
(
- Contribution to journal › Article
-
Mark
Regulation of cell-cell adhesion in prostate cancer cells by microRNA-96 through upregulation of E-Cadherin and EpCAM
(
- Contribution to journal › Article
-
Mark
Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years
(
- Contribution to journal › Article
-
Mark
Reply by Authors
(
- Contribution to journal › Article
-
Mark
Genetic risk factors for venous thromboembolism
(
- Contribution to journal › Scientific review